GPX4 and hepatocellular carcinoma: The results of Western blot analysis confirmed that Atorvastatin decreases the expression of ferroptosis-related proteins GPX4, xCT, and Ferritin in HCC cells, while the ferroptosis inhibitor Fer-1 significantly reversed this trend (Figure 9D).